Source: Clinical rheumatology. Unidade: FM
Subjects: LÚPUS ERITEMATOSO SISTÊMICO, PROTEÍNAS PROTO-ONCOGÊNICAS, PROTEÍNAS QUINASES, RECEPTORES IMUNOLÓGICOS, ARTRITE REUMATOIDE JUVENIL, NEFRITE, ANTICORPOS
ABNT
LIPHAUS, Bernadete L; LIMA, Laila; PALMEIRA, Patricia; et al. Increased sMer, but not sAxl, sTyro3, and Gas6 relate with active disease in juvenile systemic lupus erythematosus. Clinical rheumatology, London, v. 39, n. 2, p. 509-514, 2020. Disponível em: < http://observatorio.fm.usp.br/handle/OPI/35496 > DOI: 10.1007/s10067-019-04799-5.APA
Liphaus, B. L., Lima, L., Palmeira, P., Silva, C. A., Schainberg, C. G., & Sampaio, M. M. S. C. (2020). Increased sMer, but not sAxl, sTyro3, and Gas6 relate with active disease in juvenile systemic lupus erythematosus. Clinical rheumatology, 39( 2), 509-514. doi:10.1007/s10067-019-04799-5NLM
Liphaus BL, Lima L, Palmeira P, Silva CA, Schainberg CG, Sampaio MMSC. Increased sMer, but not sAxl, sTyro3, and Gas6 relate with active disease in juvenile systemic lupus erythematosus [Internet]. Clinical rheumatology. 2020 ; 39( 2): 509-514.Available from: http://observatorio.fm.usp.br/handle/OPI/35496Vancouver
Liphaus BL, Lima L, Palmeira P, Silva CA, Schainberg CG, Sampaio MMSC. Increased sMer, but not sAxl, sTyro3, and Gas6 relate with active disease in juvenile systemic lupus erythematosus [Internet]. Clinical rheumatology. 2020 ; 39( 2): 509-514.Available from: http://observatorio.fm.usp.br/handle/OPI/35496